Acute Anterior Uveitis Following Intravenous Zoledronate for Osteoporosis

Abstract

Postmenopausal osteoporosis is a common health issue clinicians encounter in practice for which bisphosphonates are commonly prescribed with success. However, these agents may cause intolerable gastrointestinal side effects when administered orally. In such cases, intravenous (IV) bisphosphonates may be prescribed. Post-infusion transient side effects are common, but more uncommon severe adverse effects may develop. We report a case of acute anterior uveitis following the use of IV zoledronate.